Innovative Technology Continues to be
Recognized by Industry Peers
LAKE
FOREST, Calif., July 17,
2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:
BIOL), the global leader in dental lasers, announced that its Epic
Hygiene dental laser, the only hygiene dental laser cleared by
the U.S. Food and Drug Administration (FDA) for laser bacterial
reduction, has been awarded Cellerant's 2023 Best of Class Hygiene
Award.
The Cellerant Best of Class Hygiene Awards program was created
by Cellerant Consulting and its founder and CEO Lou Shuman, DMD, CAGS, to honor standout dental
products designed for use during dental hygiene appointments. The
Cellerant Best of Class Technology Awards identify and acknowledge
the top technologies in dentistry and recognize innovative products
that set a standard of quality in their respective categories.
The Cellerant Best of Class Hygiene Award
selection panel consists of nine renowned thought leaders and
educators who, over the course of each year, will seek out and
conduct research on potentially practice-changing technologies,
with deliberations on nominees and final voting taking place in
February. Panelists are precluded from voting in any category where
they have consulting relationships. The entire selection process is
conducted and managed on a not-for-profit basis.
"Our dental laser technology enables dentists to enhance the
standard of care and improve patient outcomes while advancing the
quality of life," said John Beaver,
BIOLASE President and Chief Executive Officer. "Now, more than
ever, with the knowledge gained from the pandemic, ensuring a safer
work environment is critical to reducing exposure to infectious
pathogens and ensuring unimpeded dental care. On behalf of the
BIOLASE family, I thank the award's committee for recognizing the
aerosol-free Epic Hygiene dental laser, further validating our
leadership position in the hygiene market."
About BIOLASE
BIOLASE is a medical device company that develops,
manufactures, markets, and sells laser systems in dentistry and
medicine. BIOLASE's products advance the practice of dentistry and
medicine for patients and healthcare professionals. BIOLASE's
proprietary laser products incorporate approximately 266 patented
and 25 patent-pending technologies designed to provide biologically
and clinically superior performance with less pain and faster
recovery times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. From 1998 through December 31, 2022, BIOLASE has sold over
45,500 laser systems to date in over 80 countries around the world.
Laser products under development address BIOLASE's core dental
market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, as that
term is defined in the Private Litigation Reform Act of 1995, that
involve significant risks and uncertainties. Forward-looking
statements can be identified through the use of words such as may,"
"might," "will," "intend," "should," "could," "can," "would,"
"continue," "expect," "believe," "anticipate," "estimate,"
"predict," "outlook," "potential," "plan," "seek," and similar
expressions and variations or the negatives of these terms or other
comparable terminology. Readers are cautioned not to place undue
reliance on these forward-looking statements, which reflect
BIOLASE's current expectations and speak only as of the date of
this release. Actual results may differ materially from BIOLASE's
current expectations depending upon a number of factors. These
factors include, among others, those risks and uncertainties that
are described in the "Risk Factors" section of BIOLASE's annual
report filed on Form 10-K filed with the Securities and Exchange
Commission. Except as required by law, BIOLASE does not undertake
any responsibility to revise or update any forward-looking
statements.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-epic-hygiene-dental-laser-receives-prestigious-cellerant-best-of-class-hygiene-award-301878196.html
SOURCE BIOLASE, Inc.